HomeBUSINESS
BUSINESS

Nissui Pharma to Invest in Keio Univ. Spinoff Specializing in Saliva-Based Tests
(Dec.28.2017)

Japanese clinical diagnostics supplier Nissui Pharmaceutical said on December 26 that it will invest 100 million yen in SalivaTech, a saliva testing upstart originating from Keio University, through a third-party share allocation scheme ...
(LOG IN FOR FULL STORY)